DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/sxxxt7/hand_foot_and) has announced the addition of the "Hand, Foot And Mouth Disease - Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Hand, Foot And Mouth Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hand, Foot And Mouth Disease and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- Chongqing Zhifei Biological Products Co., Ltd.
- CJ CheilJedang Corp.
- iQur Ltd.
- Sentinext Therapeutics Sdn Bhd
- Sinovac Biotech Ltd.
- Takeda Pharmaceutical Company Limited
- enterovirus [type 71] vaccine
- foot and mouth disease virus like particle vaccine
- hand foot and mouth disease vaccine
- hand, foot and mouth (bivalent) viral like particle vaccine
For more information visit http://www.researchandmarkets.com/research/sxxxt7/hand_foot_and